Weekly Recap | KEYMED BIO-B -0.37%, most brokers rate it buyWeekly Review·Oct 24, 2026 at 05:16 AM02162+7.88%
Weekly Recap | KEYMED BIO-B +2.57%, revenue up over two-foldWeekly Review·Oct 17, 2026 at 05:40 AM02162+7.88%
Weekly Recap | KEYMED BIO-B +1.42%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 05:19 AM02162+7.88%
Weekly Recap | KEYMED BIO-B +7.79%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 05:25 AM02162+7.88%
Weekly Recap | KEYMED BIO-B -6.14%, consensus target above spotWeekly Review·Sep 26, 2026 at 05:12 AM02162+7.88%
